Human Reproductive Technologies: Products and Global Markets
Report Scope:
The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants, and investigates pipeline products and technologies.
The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.
Infertility market — male and female factors, pharmaceuticals, and future advancements.
Sexual dysfunction — pharmaceuticals and devices.
Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.
Report Includes:
The report is designed to be a comprehensive business tool to provide an in-depth look at the markets for reproductive drugs and technologies. The geographic scope of the report is global. The report reviews male and female reproductive health, presents standard pharmaceutical treatments and devices, and reviews technologies associated with reproductive health. The report also explores market size, identifies market participants, and investigates pipeline products and technologies.
The global market for reproductive technologies and products is divided into categories by treatment type and indication as follows.
Infertility market — male and female factors, pharmaceuticals, and future advancements.
- IVF.
- Assistive reproductive technologies.
- Fertility diagnostics.
Sexual dysfunction — pharmaceuticals and devices.
Each area is covered in detail, describing the disorder or treatment involved, identifying current products and treatments in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.
Report Includes:
- 36 data tables and 22 additional tables
- An updated review of the global markets for human reproductive products and technologies
- Analyses of the global market trends, with data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Evaluation and forecast the overall market size, projected growth trends, and corresponding market share analysis by treatment type, disease indication, end-user vertical, and geographic region
- In-depth information (facts and figures) concerning market drivers, market deterrents and other demographic and economic factors influencing the progress of this reproductive health market
- Discussion of the emerging technology trends, opportunities and gaps in the market estimating current and future demand for reproductive drugs and technologies, and COVID-19 implications within the marketplace
- Identification of promising new products and technologies still in the development and pipeline stage, and assess the probability that they will be commercialized successfully in the next five years
- Review of the company competitive landscape for global human reproductive drugs market, their product portfolios, global rankings, and company value share analysis based on segmental revenues
- Key merger and acquisition deals, new product launches, and other strategic alliances within the industry
- A relevant patent analysis
- Descriptive company profiles of the leading global players, including Actavis,Inc., Bayer AG, EMD Serono,Inc. and Quidel Corp.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Methodology
Information Source
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Introduction
CHAPTER 3 INDUSTRY OVERVIEW
Structure and Function of the Reproductive System
Male
Female
Neuroendocrine Regulation
Menarche
Menstruation Cycle
Phases of Sexual Responses
Male Sexual Response
Female Sexual Response
Neurohormonal Control of the Female and Male Reproductive System
Effects of Aging
Issues and Trends of Reproductive Health
Contraceptive Insurance
Over-the-Counter Birth Control Pills
Pre-Implantation Genetic Diagnosis
Designer Babies
New Use for Contraceptives
Aging and Infertility
Death by Contraceptive Patch
Sexual Dysfunction and Cancer
Infertility and Cancer
Signaling Pathway for Fertility Treatment
Marketing Tactics
Male Birth Control
Merchandising Targeting Women
Counterfeit Products
Surplus Embryos and Fetuses
Stem Cell and Other Controversial Issues — Selected International Views
Controversial Disposal of Embryos
Demographics
CHAPTER 4 INFERTILITY MARKET
Introduction and Overview of Infertility
Definition of Infertility
Etiology of Infertility
Evaluation of Fertility
Unexplained Infertility
Multiple Births
Asia Factor
CHAPTER 5 COVID-19 IMPACT
Introduction
COVID-19: Impact on the Medical Devices and Pharma Industries
Decline/Delay in Elective Procedures
COVID-19 Impact on Supply Chain
U.S. Supply Chain: COVID-19 Impact
European Supply Chain: COVID-19 Impact
APAC Supply Chain: COVID-19 Impact
China: COVID-19 Impact
COVID-19 Impact on Medical Device and Pharmaceutical Product Segments
COVID-19 Impact on Critical Devices
COVID-19 Impact on Human Reproductive Technologies and Products Markets
CHAPTER 6 METHODS OF TREATMENT
Fertility Pharmaceuticals
Introduction and Types
Market Revenues and Forecast
Future Advancements in Infertility Products
Competitive Analysis
CHAPTER 7 ASSISTIVE REPRODUCTIVE TECHNOLOGIES
Introduction
Types
IVF
Ovulation Induction
Oocyte Retrieval
Intracytoplasmic Sperm Injection (ICSI)
Fertilization
Embryo Transfer
Results of IVF
GIFT
ZIFT
Wombs for Rent
Oocyte Donation
Frozen Embryos
United States Fertility Clinics
Market Revenues and Forecast
Future Trends in Assistive Reproductive Technology
Competitive Analysis
CHAPTER 8 FERTILITY DIAGNOSTICS
Introduction
Types
Urine Studies
Market Revenues and Forecast
Competitive Analysis
Future Advancements in Diagnostic Fertility Treatment
Total Infertility Market Revenues and Forecast
CHAPTER 9 CONTRACEPTION MARKET
Introduction and Overview of Contraception
Pharmaceuticals
Types
Other Drug Regimens for Contraception
Market Revenues and Forecast
Competitive Analysis
Prescription Devices
Market Revenues and Forecast
Competitive Analysis
Future Advancements in Contraception
Total Market Revenues and Forecast
CHAPTER 10 SEXUAL DYSFUNCTION MARKET
Introduction and Overview
Types of Sexual Dysfunction
Causes of Sexual Dysfunction
Demographics of Sexual Dysfunction
Pharmaceuticals
Introduction and Types
Market Revenues and Forecast
Competitive Analysis
Devices
Market Revenues and Forecast
Future Advancements in Sexual Dysfunction
Total Market Revenues and Forecast
CHAPTER 11 PATENTS
Patent Analysis by Manufacturer
Patent by Company
Patents by Application
Infertility Treatments
Contraception
Sexual Dysfunction
Leading Market Manufacturers
CHAPTER 12 TOTAL MARKET
Total Global Market for Reproductive Technologies and Products, by Region
North America
Europe
Asia-Pacific
Rest of the World
Total Market Size by Category
Industry Participants by Category
Total Market Size by Product Type
CHAPTER 13 COMPETITIVE LANDSCAPE
Competitive Analysis
CHAPTER 14 COMPANY PROFILES
ACTAVIS, INC.
BAYER AG
BRISTOL-MYERS SQUIBB CO.
CHURCH & DWIGHT COMPANY INC.
COOPERSURGICAL INC.
ELI LILLY & CO.
EMD SERONO, INC.
FERRING PHARMACEUTICALS
GLAXOSMITHKLINE PLC
JANSSEN PHARMACEUTICAL
MERCK INC.
NOVARTIS INTERNATIONAL AG
PFIZER INC.
PRINCETON BIOMEDITECH CORP.
QUIDEL CORP.
TEVA PHARMACEUTICALS.
VIVUS INC.
Selected List of U.S. Fertility Clinics
List of Companies
CHAPTER 15 APPENDIX: ACRONYMS
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update?
Scope of Report
Methodology
Information Source
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Introduction
CHAPTER 3 INDUSTRY OVERVIEW
Structure and Function of the Reproductive System
Male
Female
Neuroendocrine Regulation
Menarche
Menstruation Cycle
Phases of Sexual Responses
Male Sexual Response
Female Sexual Response
Neurohormonal Control of the Female and Male Reproductive System
Effects of Aging
Issues and Trends of Reproductive Health
Contraceptive Insurance
Over-the-Counter Birth Control Pills
Pre-Implantation Genetic Diagnosis
Designer Babies
New Use for Contraceptives
Aging and Infertility
Death by Contraceptive Patch
Sexual Dysfunction and Cancer
Infertility and Cancer
Signaling Pathway for Fertility Treatment
Marketing Tactics
Male Birth Control
Merchandising Targeting Women
Counterfeit Products
Surplus Embryos and Fetuses
Stem Cell and Other Controversial Issues — Selected International Views
Controversial Disposal of Embryos
Demographics
CHAPTER 4 INFERTILITY MARKET
Introduction and Overview of Infertility
Definition of Infertility
Etiology of Infertility
Evaluation of Fertility
Unexplained Infertility
Multiple Births
Asia Factor
CHAPTER 5 COVID-19 IMPACT
Introduction
COVID-19: Impact on the Medical Devices and Pharma Industries
Decline/Delay in Elective Procedures
COVID-19 Impact on Supply Chain
U.S. Supply Chain: COVID-19 Impact
European Supply Chain: COVID-19 Impact
APAC Supply Chain: COVID-19 Impact
China: COVID-19 Impact
COVID-19 Impact on Medical Device and Pharmaceutical Product Segments
COVID-19 Impact on Critical Devices
COVID-19 Impact on Human Reproductive Technologies and Products Markets
CHAPTER 6 METHODS OF TREATMENT
Fertility Pharmaceuticals
Introduction and Types
Market Revenues and Forecast
Future Advancements in Infertility Products
Competitive Analysis
CHAPTER 7 ASSISTIVE REPRODUCTIVE TECHNOLOGIES
Introduction
Types
IVF
Ovulation Induction
Oocyte Retrieval
Intracytoplasmic Sperm Injection (ICSI)
Fertilization
Embryo Transfer
Results of IVF
GIFT
ZIFT
Wombs for Rent
Oocyte Donation
Frozen Embryos
United States Fertility Clinics
Market Revenues and Forecast
Future Trends in Assistive Reproductive Technology
Competitive Analysis
CHAPTER 8 FERTILITY DIAGNOSTICS
Introduction
Types
Urine Studies
Market Revenues and Forecast
Competitive Analysis
Future Advancements in Diagnostic Fertility Treatment
Total Infertility Market Revenues and Forecast
CHAPTER 9 CONTRACEPTION MARKET
Introduction and Overview of Contraception
Pharmaceuticals
Types
Other Drug Regimens for Contraception
Market Revenues and Forecast
Competitive Analysis
Prescription Devices
Market Revenues and Forecast
Competitive Analysis
Future Advancements in Contraception
Total Market Revenues and Forecast
CHAPTER 10 SEXUAL DYSFUNCTION MARKET
Introduction and Overview
Types of Sexual Dysfunction
Causes of Sexual Dysfunction
Demographics of Sexual Dysfunction
Pharmaceuticals
Introduction and Types
Market Revenues and Forecast
Competitive Analysis
Devices
Market Revenues and Forecast
Future Advancements in Sexual Dysfunction
Total Market Revenues and Forecast
CHAPTER 11 PATENTS
Patent Analysis by Manufacturer
Patent by Company
Patents by Application
Infertility Treatments
Contraception
Sexual Dysfunction
Leading Market Manufacturers
CHAPTER 12 TOTAL MARKET
Total Global Market for Reproductive Technologies and Products, by Region
North America
Europe
Asia-Pacific
Rest of the World
Total Market Size by Category
Industry Participants by Category
Total Market Size by Product Type
CHAPTER 13 COMPETITIVE LANDSCAPE
Competitive Analysis
CHAPTER 14 COMPANY PROFILES
ACTAVIS, INC.
BAYER AG
BRISTOL-MYERS SQUIBB CO.
CHURCH & DWIGHT COMPANY INC.
COOPERSURGICAL INC.
ELI LILLY & CO.
EMD SERONO, INC.
FERRING PHARMACEUTICALS
GLAXOSMITHKLINE PLC
JANSSEN PHARMACEUTICAL
MERCK INC.
NOVARTIS INTERNATIONAL AG
PFIZER INC.
PRINCETON BIOMEDITECH CORP.
QUIDEL CORP.
TEVA PHARMACEUTICALS.
VIVUS INC.
Selected List of U.S. Fertility Clinics
List of Companies
CHAPTER 15 APPENDIX: ACRONYMS
LIST OF TABLES
Summary Table: Global Market for Human Reproductive Technologies and Products, by Product Type, Through 2027
Table 1: Structural Homologues of the Male and Female Reproductive Systems
Table 2: U.S. Live Birth Rates, 2000-2020
Table 3: U.S. Population, by Selected Age Groups, and by Percent of Total Population, 2010-2030
Table 4: Characteristics of Women Who Have Had a Child in the Last Year, 2008 and 2010
Table 5: Women Who Have Had a Child in the Last Year, by Age and Labor FORCE Status, 1980-2008
Table 6: Contraceptive Use Share, by Type, by Age, Ethnic Group and Marital Status
Table 7: Birth Rate in Europe, by Country and Year, 1960-2020
Table 8: Selected Prescription Fertility Drugs
Table 9: Global Infertility Pharmaceuticals Market, Through 2027
Table 10: Infertility Drugs in Development
Table 11: Global Infertility Pharmaceutical Manufacturer Market, 2021
Table 12: National Summary of Assistive Reproductive Therapies in U.S., 2020
Table 13: National Assistive Reproductive Therapies Cycle Profile, 2019
Table 14: Pregnancy Success Rates, 2019
Table 15: Number of IVF Clinics/Centers by Selected Countries
Table 16: Global Assistive Reproductive Technologies Market, Through 2027
Table 17: Global Infertility Assistive Reproductive Products Manufacturer Market, 2021
Table 18: Global Fertility Diagnostics Market, by Product Type, Through 2027
Table 19: Global Fertility Diagnostic Manufacturer Market, 2021
Table 20: Global Infertility Treatments Market, by Product Type, Through 2027
Table 21: Contraceptive Status and Use Rates, U.S. Women Aged 15-49, 2015-2017
Table 22: Contraceptive Use, by Region, 2015 and 2030
Table 23: Most Commonly Used Oral and Transdermal Contraceptives
Table 24: Estrogen and Progestin Hormone Doses in Combined Birth Control Pills
Table 25: Potency of Different Oral Contraceptive Progestins
Table 26: Current Pill Problems and Choice of Pill to Switch To
Table 27: Global Contraceptive Pharmaceuticals Market, by Product Type, Through 2027
Table 28: Global Contraceptive Pharmaceutical Manufacturer Market, 2021
Table 29: Selected Contraceptive Device Treatments, 2021
Table 30: Global Contraceptive Devices Market, by Product Type, Through 2027
Table 31: Global Contraceptive Device Manufacturer Market, 2021
Table 32: Contraceptives in Development
Table 33: Global Contraceptive Products Market, by Product Type, Through 2027
Table 34: Selected Sexual Dysfunction Pharmaceutical Treatments
Table 35: Global Sexual Dysfunction Pharmaceuticals Market, by Product Type, Through 2027
Table 36: Global Sexual Dysfunction Pharmaceuticals Manufacturer Market, 2021
Table 37: Selected Sexual Dysfunction Device Treatments
Table 38: Global Sexual Dysfunction Devices Market, by Product Type, Through 2027
Table 39: Global Sexual Dysfunction Devices Manufacturer Market, 2021
Table 40: Sexual Dysfunction Drugs in Development
Table 41: Global Sexual Dysfunction Treatments Market, by Product Type, Through 2027
Table 42: Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 2015-Present
Table 43: Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 1976-Present
Table 44: Patent Analysis, by Selected Leading Reproductive Treatment Manufacturer, 1976-Present
Table 45: Global Reproductive Technologies and Products Market, Through 2027
Table 46: Global Reproductive Technologies and Products Market, by Region, Through 2027
Table 47: North American Reproductive Technologies and Products Market, by Country, Through 2027
Table 48: European Reproductive Technologies and Products Market, by Country, Through 2027
Table 49: Asia-Pacific Reproductive Technologies and Products Market, by Country, Through 2027
Table 50: RoW Reproductive Technologies and Products Market, Through 2027
Table 51: Global Reproductive Technologies and Products Market, by Region, 2021
Table 52: Global Reproductive Technologies and Products Market, by Region, 2027
Table 53: Global Reproductive Technologies and Products Market, by Product Type, Through 2027
Table 54: Global Reproductive Technologies and Products Market, 2019
Table 55: Reproductive Industry Participants, by Product Category
Table 56: Global Reproductive Technologies and Products Market, by Product Type, Through 2017
Table 57: List of Companies
Table 58: Acronyms Used in This Report
Summary Table: Global Market for Human Reproductive Technologies and Products, by Product Type, Through 2027
Table 1: Structural Homologues of the Male and Female Reproductive Systems
Table 2: U.S. Live Birth Rates, 2000-2020
Table 3: U.S. Population, by Selected Age Groups, and by Percent of Total Population, 2010-2030
Table 4: Characteristics of Women Who Have Had a Child in the Last Year, 2008 and 2010
Table 5: Women Who Have Had a Child in the Last Year, by Age and Labor FORCE Status, 1980-2008
Table 6: Contraceptive Use Share, by Type, by Age, Ethnic Group and Marital Status
Table 7: Birth Rate in Europe, by Country and Year, 1960-2020
Table 8: Selected Prescription Fertility Drugs
Table 9: Global Infertility Pharmaceuticals Market, Through 2027
Table 10: Infertility Drugs in Development
Table 11: Global Infertility Pharmaceutical Manufacturer Market, 2021
Table 12: National Summary of Assistive Reproductive Therapies in U.S., 2020
Table 13: National Assistive Reproductive Therapies Cycle Profile, 2019
Table 14: Pregnancy Success Rates, 2019
Table 15: Number of IVF Clinics/Centers by Selected Countries
Table 16: Global Assistive Reproductive Technologies Market, Through 2027
Table 17: Global Infertility Assistive Reproductive Products Manufacturer Market, 2021
Table 18: Global Fertility Diagnostics Market, by Product Type, Through 2027
Table 19: Global Fertility Diagnostic Manufacturer Market, 2021
Table 20: Global Infertility Treatments Market, by Product Type, Through 2027
Table 21: Contraceptive Status and Use Rates, U.S. Women Aged 15-49, 2015-2017
Table 22: Contraceptive Use, by Region, 2015 and 2030
Table 23: Most Commonly Used Oral and Transdermal Contraceptives
Table 24: Estrogen and Progestin Hormone Doses in Combined Birth Control Pills
Table 25: Potency of Different Oral Contraceptive Progestins
Table 26: Current Pill Problems and Choice of Pill to Switch To
Table 27: Global Contraceptive Pharmaceuticals Market, by Product Type, Through 2027
Table 28: Global Contraceptive Pharmaceutical Manufacturer Market, 2021
Table 29: Selected Contraceptive Device Treatments, 2021
Table 30: Global Contraceptive Devices Market, by Product Type, Through 2027
Table 31: Global Contraceptive Device Manufacturer Market, 2021
Table 32: Contraceptives in Development
Table 33: Global Contraceptive Products Market, by Product Type, Through 2027
Table 34: Selected Sexual Dysfunction Pharmaceutical Treatments
Table 35: Global Sexual Dysfunction Pharmaceuticals Market, by Product Type, Through 2027
Table 36: Global Sexual Dysfunction Pharmaceuticals Manufacturer Market, 2021
Table 37: Selected Sexual Dysfunction Device Treatments
Table 38: Global Sexual Dysfunction Devices Market, by Product Type, Through 2027
Table 39: Global Sexual Dysfunction Devices Manufacturer Market, 2021
Table 40: Sexual Dysfunction Drugs in Development
Table 41: Global Sexual Dysfunction Treatments Market, by Product Type, Through 2027
Table 42: Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 2015-Present
Table 43: Selected Manufacturer Patents for Reproductive Products and Related Technology, by Application, 1976-Present
Table 44: Patent Analysis, by Selected Leading Reproductive Treatment Manufacturer, 1976-Present
Table 45: Global Reproductive Technologies and Products Market, Through 2027
Table 46: Global Reproductive Technologies and Products Market, by Region, Through 2027
Table 47: North American Reproductive Technologies and Products Market, by Country, Through 2027
Table 48: European Reproductive Technologies and Products Market, by Country, Through 2027
Table 49: Asia-Pacific Reproductive Technologies and Products Market, by Country, Through 2027
Table 50: RoW Reproductive Technologies and Products Market, Through 2027
Table 51: Global Reproductive Technologies and Products Market, by Region, 2021
Table 52: Global Reproductive Technologies and Products Market, by Region, 2027
Table 53: Global Reproductive Technologies and Products Market, by Product Type, Through 2027
Table 54: Global Reproductive Technologies and Products Market, 2019
Table 55: Reproductive Industry Participants, by Product Category
Table 56: Global Reproductive Technologies and Products Market, by Product Type, Through 2017
Table 57: List of Companies
Table 58: Acronyms Used in This Report
LIST OF FIGURES
Summary Figure A: Global Market for Human Reproductive Technologies and Products, by Product Type, 2019-2027
Summary Figure B: Global Market Share of Human Reproductive Technologies and Products, by Product Type, 2021
Figure 1: U.S. Live Birth Rates, 2000-2020
Figure 2: U.S. Population Selected Age Groups, by Percent of Total Population, 2010-2030
Figure 3: Global Infertility Pharmaceutical Manufacturer Market Share, 2021
Figure 4: Global Infertility Assistive Reproductive Products Manufacturer Market Share, 2021
Figure 5: Global Fertility Diagnostic Manufacturer Market Share, 2021
Figure 6: Global Infertility Treatments Market, by Product Type, 2019-2027
Figure 7: Global Contraceptive Pharmaceuticals Manufacturer Market Share, 2021
Figure 8: Global Contraceptive Device Manufacturer Market Share, 2021
Figure 9: Global Contraceptive Products Market, by Product Type, 2019-2027
Figure 10: Global Sexual Dysfunction Pharmaceuticals Manufacturer Market Share, 2021
Figure 11: Global Sexual Dysfunction Devices Manufacturer Market Share, 2021
Figure 12: Global Sexual Dysfunction Treatments Market, by Product Type , 2019-2027
Figure 13: Global Reproductive Technologies and Products Market Share, by Region, 2021
Figure 14: Global Reproductive Technologies and Products Market Share, by Region, 2027
Figure 15: Global Reproductive Technologies and Products Market, by Product Type, 2019-2027
Figure 16: Number of Selected Manufacturers, by Segment, 2019
Figure 17: Global Reproductive Technologies and Products Market Share, 2019
Figure 18: Global Reproductive Technologies and Products Market, by Product Type, 2019-2027
Summary Figure A: Global Market for Human Reproductive Technologies and Products, by Product Type, 2019-2027
Summary Figure B: Global Market Share of Human Reproductive Technologies and Products, by Product Type, 2021
Figure 1: U.S. Live Birth Rates, 2000-2020
Figure 2: U.S. Population Selected Age Groups, by Percent of Total Population, 2010-2030
Figure 3: Global Infertility Pharmaceutical Manufacturer Market Share, 2021
Figure 4: Global Infertility Assistive Reproductive Products Manufacturer Market Share, 2021
Figure 5: Global Fertility Diagnostic Manufacturer Market Share, 2021
Figure 6: Global Infertility Treatments Market, by Product Type, 2019-2027
Figure 7: Global Contraceptive Pharmaceuticals Manufacturer Market Share, 2021
Figure 8: Global Contraceptive Device Manufacturer Market Share, 2021
Figure 9: Global Contraceptive Products Market, by Product Type, 2019-2027
Figure 10: Global Sexual Dysfunction Pharmaceuticals Manufacturer Market Share, 2021
Figure 11: Global Sexual Dysfunction Devices Manufacturer Market Share, 2021
Figure 12: Global Sexual Dysfunction Treatments Market, by Product Type , 2019-2027
Figure 13: Global Reproductive Technologies and Products Market Share, by Region, 2021
Figure 14: Global Reproductive Technologies and Products Market Share, by Region, 2027
Figure 15: Global Reproductive Technologies and Products Market, by Product Type, 2019-2027
Figure 16: Number of Selected Manufacturers, by Segment, 2019
Figure 17: Global Reproductive Technologies and Products Market Share, 2019
Figure 18: Global Reproductive Technologies and Products Market, by Product Type, 2019-2027
